Lawsuits claim the company, Philips Respironics, knew of problems with its CPAP and other machines long before notifying customers of potential health risks.
Especially for Black patients, inaccurate readings have imperiled care and may have contributed to deaths during the pandemic, experts told an advisory panel.
The pharmaceutical industry finances about 75 percent of the agency’s drug division, through a controversial program that Congress must reauthorize by the end of this month.